Soluble E-cadherin: A marker of genital epithelial disruption

被引:7
|
作者
Liu, Rachel [1 ,6 ]
Armstrong, Eric [1 ]
Constable, Shirley [3 ]
Buchanan, Lane B. [3 ]
Mohammadi, Avid [1 ]
Galiwango, Ronald M. [1 ]
Huibner, Sanja [1 ]
Perry, Marie C. [4 ]
Prodger, Jessica L. [3 ]
Coburn, Bryan [1 ,2 ,4 ,5 ]
Kaul, Rupert [1 ,2 ,4 ,5 ]
机构
[1] Univ Toronto, Dept Med, Toronto, ON, Canada
[2] Univ Hlth Network, Toronto Gen Hosp Res Inst, Toronto, ON, Canada
[3] Western Univ, Schulich Sch Med & Dent, Dept Microbiol & Immunol, London, ON, Canada
[4] Univ Toronto, Dept Immunol, Toronto, ON, Canada
[5] Univ Hlth Network, Dept Med, Toronto, ON, Canada
[6] 1 Kings Coll Cir, Toronto, ON M5S 1A8, Canada
关键词
E-cadherin; epithelial disruption; genital immunology; HIV prevention; HIV-INFECTION; PERMEABILITY; JUNCTIONS; MECHANISM; BARRIER; ULCERS;
D O I
10.1111/aji.13674
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
ProblemThe genital epithelial barrier is a crucial first line of defence against HIV, and epithelial disruption may enhance HIV susceptibility. Assessment of genital epithelial integrity requires biopsies, but their collection is not practical in many research settings. A validated biomarker of genital epithelial barrier integrity would therefore be useful. The purpose of this study was to evaluate soluble E-cadherin (sE-cad) as a marker of genital epithelial disruption. Method of studyUsing in vitro models of endocervical and foreskin epithelial cells, we assessed changes in sE-cad, IL-6, IL-1 beta, and IL-1 alpha levels following mechanical disruption. We also assessed changes in sE-cad levels in vivo in cervicovaginal secretions after epithelial disruption by endocervical cytobrush sampling in Canadian women, and assessed the relationship between levels of sE-cad in coronal sulcus swabs to membrane-bound E-cadherin in the overlying foreskin tissue in Ugandan men. ResultssE-cad levels immediately increased after in vitro epithelial physical disruption with the degree of elevation dependent on the extent of disruption, as did levels of IL-1 beta and IL-1 alpha; this was followed by a delayed increase in IL-6 levels. In vivo results confirmed that sE-cad levels in cervicovaginal secretions were elevated 6 h after cytobrush sampling when compared to baseline. Furthermore, levels of sE-cad in the prepuce were inversely correlated with the amount of membrane-bound E-cadherin of overlying tissue. ConclusionOur results validate the use of sE-cad as a marker of epithelial disruption and demonstrate that the processes of physical disruption and inflammation in the genital tract are strongly intertwined.
引用
收藏
页数:9
相关论文
共 50 条
  • [1] An SPR based immunoassay for the sensitive detection of the soluble epithelial marker E-cadherin
    Vergara, Daniele
    Bianco, Monica
    Pagano, Rosanna
    Priore, Paola
    Lunetti, Paola
    Guerra, Flora
    Bettini, Simona
    Carallo, Sonia
    Zizzari, Alessandra
    Pitotti, Elena
    Giotta, Livia
    Capobianco, Loredana
    Bucci, Cecilia
    Valli, Ludovico
    Maffia, Michele
    Arima, Valentina
    Gaballo, Antonio
    NANOMEDICINE-NANOTECHNOLOGY BIOLOGY AND MEDICINE, 2018, 14 (07) : 1963 - 1971
  • [2] SOLUBLE E-CADHERIN - A NOVEL CUTANEOUS DISEASE MARKER
    MATSUYOSHI, N
    TANAKA, T
    TODA, K
    OKAMOTO, H
    FURUKAWA, F
    IMAMURA, S
    BRITISH JOURNAL OF DERMATOLOGY, 1995, 132 (05) : 745 - 749
  • [3] Soluble serum E-cadherin for tumor marker in gastric cancer
    Shiozaki, H
    Nakanishi, J
    Gofuku, J
    Oka, H
    Doki, Y
    Tamura, S
    Inoue, M
    Monden, M
    PROGRESS IN GASTRIC CANCER RESEARCH 1997: PROCEEDINGS OF THE 2ND INTERNATIONAL GASTRIC CANCER CONGRESS, 1997, : 437 - 440
  • [4] Soluble E-cadherin is a valid prognostic marker in gastric carcinoma
    Chan, AOO
    Lam, SK
    Chu, KM
    Lam, CM
    Kwok, E
    Leung, SY
    Yuen, ST
    Law, SYK
    Hui, WM
    Lai, KC
    Wong, CY
    Hu, HC
    Lai, CL
    Wong, J
    GUT, 2001, 48 (06) : 808 - 811
  • [5] Characterization of soluble E-cadherin as a disease marker in gastric cancer patients
    Gofuku, J
    Shiozaki, H
    Doki, Y
    Inoue, M
    Hirao, M
    Fukuchi, N
    Monden, M
    BRITISH JOURNAL OF CANCER, 1998, 78 (08) : 1095 - 1101
  • [6] Characterization of soluble E-cadherin as a disease marker in gastric cancer patients
    J Gofuku
    H Shiozaki
    Y Doki
    M Inoue
    M Hirao
    N Fukuchi
    M Monden
    British Journal of Cancer, 1998, 78 : 1095 - 1101
  • [7] Elevated soluble E-cadherin during the epithelial-mesenchymal transition process and as a diagnostic marker in colorectal cancer
    Zhu, Shuzhen
    Zhao, Guanghui
    Zhao, Xiaoyun
    Zhan, Xiaohong
    Cai, Meijuan
    Geng, Congcong
    Pu, Qian
    Zhao, Qianqian
    Fu, Qingsong
    Huang, Chunxiao
    Wang, Qian
    GENE, 2020, 754
  • [8] Cleavage of E-cadherin:: a mechanism for disruption of the intestinal epithelial barrier by Candida albicans
    Frank, Charlotte F.
    Hostetter, Margaret K.
    TRANSLATIONAL RESEARCH, 2007, 149 (04) : 211 - 222
  • [9] Serum soluble E-cadherin is a new potential marker for assessing the severity of gout
    Zhao, Q.
    Xiong, Y.
    Man, X.
    Liu, Y.
    Huang, Y.
    Chen, W.
    Wang, B.
    CLINICAL AND EXPERIMENTAL RHEUMATOLOGY, 2023, 41 (05) : 1170 - 1178
  • [10] Soluble serum E-cadherin as a marker of tumour progression in colorectal cancer patients
    C. Wilmanns
    J. Grossmann
    S. Steinhauer
    G. Manthey
    B. Weinhold
    A. Schmitt-Gräff
    B.-U. von Specht
    Clinical & Experimental Metastasis, 2004, 21 : 75 - 78